blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1206272

EP1206272 - HYBRID POLYPEPTIDES WITH ENHANCED PHARMACOKINETIC PROPERTIES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.07.2009
Database last updated on 31.08.2024
Most recent event   Tooltip24.07.2009Application deemed to be withdrawnpublished on 26.08.2009  [2009/35]
Applicant(s)For all designated states
TRIMERIS INC.
4727 University Drive
Durham, NC 27707-3438 / US
[2002/21]
Inventor(s)01 / BARNEY, Shawn
106 Branchway Road
Apex, NC 27502 / US
02 / GUTHRIE, Kelly, I.
2317 Leeward Shore Drive
Virginia Beach, VA 23451 / US
03 / MERUTKA, Gene
18456 Purdue Drive
Saratoga, CA 27278 / US
04 / ANWER, Mohmed, K.
81 Foster City Boulevard 112
Foster City, CA 94404 / US
05 / LAMBERT, Dennis, M.
101 Centerville Court
Cary, NC 27513 / US
 [2002/21]
Representative(s)Naylor, Kathryn May, et al
Mathys & Squire LLP 120 Holborn London
EC1N 2SQ / GB
[N/P]
Former [2007/18]Naylor, Kathryn May, et al
Mathys & Squire 120 Holborn
London EC1N 2SQ / GB
Former [2003/14]Adams, Harvey Vaughan John, et al
Mathys & Squire, 100 Gray's Inn Road
London WC1X 8AL / GB
Former [2002/21]Schlich, George William, et al
Mathys & Squire European Patent Attorneys, 100 Gray's Inn Road
London WC1X 8AL / GB
Application number, filing date00947166.510.07.2000
[2002/21]
WO2000US18772
Priority number, dateUS1999035064109.07.1999         Original published format: US 350641
[2002/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0103723
Date:18.01.2001
Language:EN
[2001/03]
Type: A1 Application with search report 
No.:EP1206272
Date:22.05.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 18.01.2001 takes the place of the publication of the European patent application.
[2002/21]
Search report(s)International search report - published on:US18.01.2001
(Supplementary) European search report - dispatched on:EP19.11.2002
ClassificationIPC:A61K38/02, A61K38/08, A61K38/10, A61K38/16, A61K38/18, A61K38/19, A61K38/22, C07K7/06, C07K7/08, C07K14/00, C07K7/23, C07K14/16
[2003/01]
CPC:
C07K14/005 (EP,US); C07K7/08 (KR); A61K47/62 (EP,US);
A61P31/14 (EP); A61P31/16 (EP); A61P31/18 (EP);
A61P31/20 (EP); C07K14/59 (EP,US); C07K5/1021 (EP,US);
C07K5/1024 (EP,US); A61K38/00 (EP,US); C07K2319/00 (EP,US);
C12N2740/16122 (EP,US); C12N2760/18522 (EP,US); Y02A50/30 (EP) (-)
Former IPC [2002/21]A61K38/02, A61K38/08, A61K38/10, A61K38/16, A61K38/18, A61K38/19, A61K38/22, C07K7/06, C07K7/08, C07K14/00
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/21]
Extension statesAL10.01.2002
LT10.01.2002
LV10.01.2002
MK10.01.2002
RO10.01.2002
SI10.01.2002
TitleGerman:HYBRID-POLYPEPTIDE MIT VERBESSERTEN PHARMAKOKINETISCHEN EIGENSCHAFTEN[2002/21]
English:HYBRID POLYPEPTIDES WITH ENHANCED PHARMACOKINETIC PROPERTIES[2002/21]
French:POLYPEPTIDES HYBRIDES POSSEDANT DES PROPRIETES PHARMACOCINETIQUES AMELIOREES[2002/21]
Entry into regional phase10.01.2002National basic fee paid 
10.01.2002Search fee paid 
10.01.2002Designation fee(s) paid 
10.01.2002Examination fee paid 
Examination procedure01.02.2001Request for preliminary examination filed
International Preliminary Examining Authority: US
10.01.2002Amendment by applicant (claims and/or description)
10.01.2002Examination requested  [2002/21]
11.12.2006Despatch of a communication from the examining division (Time limit: M06)
20.06.2007Reply to a communication from the examining division
22.01.2008Despatch of a communication from the examining division (Time limit: M06)
30.07.2008Reply to a communication from the examining division
20.10.2008Communication of intention to grant the patent
03.03.2009Application deemed to be withdrawn, date of legal effect  [2009/35]
07.04.2009Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2009/35]
Fees paidRenewal fee
12.07.2002Renewal fee patent year 03
14.07.2003Renewal fee patent year 04
14.07.2004Renewal fee patent year 05
13.07.2005Renewal fee patent year 06
12.07.2006Renewal fee patent year 07
13.07.2007Renewal fee patent year 08
14.07.2008Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US5358934  (BOROVSKY DOV [US], et al) [A] * page 2, column 64 - page 3, column 2 *;
 [A]EP0741187  (HOFFMANN LA ROCHE [CH]) [A] * page 9, column 19 - page 11, column 25 *;
 [E]WO0134635  (TRIMERIS INC [US]) [E] 1-8,11-16 * The whole document; see especially page 7-8; page 11; claims 4 and 5 *;
 [X]  - WILD C T ET AL, "PEPTIDES CORRESPONDING TO A PREDICTIVE ALPHA-HELICAL DOMAIN OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 GP41 ARE POTENT INHIBITORS OF VIRUS INFECTION", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, (19941001), vol. 91, ISSN 0027-8424, pages 9770 - 9774, XP002054040 [X] 11,14,19,22,32,35,41,43,45,47-52 * The whole document;see especially fig 2 and 3 *

DOI:   http://dx.doi.org/10.1073/pnas.91.21.9770
 [X]  - LAWLESS M K ET AL, "HIV-1 MEMBRANE FUSION MECHANISM: STRUCTURAL STUDIES OF THE INTERACTIONS BETWEEN BIOLOGICALLY-ACTIVE PEPTIDES FROM GP41", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, (19961022), vol. 35, no. 42, ISSN 0006-2960, pages 13697 - 13708, XP002059093 [X] 11,14,19,22,32,35,41,43,45,47-52 * page 13706; table 2 *

DOI:   http://dx.doi.org/10.1021/bi9606962
International search[X]EP0272858  (REPLIGEN CORP [US]);
 [X]WO9107664  (CAMBRIDGE BIOSCIENCE CORP [US]);
 [X]EP0578293  (AKZO NV [NL]);
 [X]US5357041  (ROBERTS DAVID D [US], et al);
 [Y]US5358934  (BOROVSKY DOV [US], et al);
 [X]US5464933  (BOLOGNESI DANI P [US], et al);
 [X]US5723129  (POTTER ANDREW A [CA], et al);
 [X]US5763160  (WANG CHANG YI [US]);
 [X]US5843913  (LI XIAOMAO [CA], et al);
 [XP]US5968776  (KLEIN MICHEL H [CA], et al);
 [XP]WO9959615  (TRIMERIS INC [US])
Examination   - MOL.ENDOCRINOL., (1995), vol. 9, pages 54 - 63
by applicantUS4179337
 US5464933
 US5876969
 US6025325
    - PAIGE ET AL., PHARM. RES., (1995), vol. 12, pages 1883 - 88
    - FURUHASHI ET AL., MOL. ENDOCRINOL., (1995), vol. 9, pages 54 - 63
    - BURNHAM, AM. J. HOSP. PHARM., (1994), vol. 51, pages 210 - 18
    - INADA ET AL., TRENDS BIOTECHNOL., (1995), vol. 13, pages 86 - 91
    - WESTERMAN ET AL., INT. J. CANCER, (1998), vol. 76, pages 842 - 50
    - CONOVER ET AL., ARTIF. ORGANS, (1997), vol. 21, pages 907 - 15
    - TSUTSUMI ET AL., J. PHARMACOL. EXP. THER., (1996), vol. 278, pages 1006 - 11
    - KANEDA ET AL., INVASION METASTASIS, (1995), vol. 15, pages 156 - 62
    - SATAKE-ISHIKAWA ET AL., CELL STRUCT. FUNCT., (1992), vol. 17, pages 157 - 60
    - TANAKA ET AL., CANCER RES., (1991), vol. 51, pages 3710 - 3714
    - ZALIPSKY ET AL., INT. J. PEPTIDE PROTEIN RES., (1987), vol. 30, page 740
    - SARTORE ET AL., APPL. BIOCHEM. BIOTECH., (1991), vol. 27, page 45
    - GREENE, Protective Groups in Orqanic Synthesis, JOHN WILEY & SONS, (1981), pages 323 - 334
    - FIELDS; NOBLE, INT. J. PEPT. PROTEIN RES., (1990), vol. 35, pages 161 - 214
    - ZOLLER ET AL., NUCL. ACIDS RES., (1987), vol. 10, page 6487
    - CARTER ET AL., NUCL. ACIDS RES., (1986), vol. 13, page 4331
    - KRATZ ET AL., ARCH. PHARM. (WEINHEIM, (1998), vol. 331, pages 47 - 53
    - SYED ET AL., BLOOD, (1997), vol. 89, pages 3243 - 3252
    - MAKRIDES ET AL., J. PHARMACOL. EXP. THER., (1996), vol. 277, pages 534 - 42
    - BRETON ET AL., EUR. J. BIOCHEM., (1995), vol. 231, pages 563 - 69
    - WEITKAMP ET AL., ANN. HUM. GENET., (1973), vol. 37, page 219
    - SAMBROOK ET AL., Molecular Cloning, A Laboratory Manual, COLD SPRING HARBOR PRESS, (1989), vol. 1-3
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.